Contribution of perospirone and risperidone to reduce delirium in senile patients

Psychogeriatrics

Volumn 8, Issue 1, 2008, Pages 4-7

  Ushijima, Michikazu ^a,b   Yokoyama, Shin ^a   Sugiyama, Eiko ^c   Amano, Naoji ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chikumaso Hospital   (Japan)

^c Nagano Prefectural College   (Japan)

Author keywords

Behavioral and psychiatric symptoms of dementia (BPSD); Clinical psychopharmacology; Delirium; Delirium Rating Scale (DRS); Perospirone; Risperidone; Senile patients

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; PEROSPIRONE; RISPERIDONE; SEROTONIN ANTAGONIST;

AGED; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DELIRIUM; DELUSION; DEMENTIA; DISEASE COURSE; DIZZINESS; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOOD AND DRUG ADMINISTRATION; GERIATRIC PATIENT; HALLUCINATION; HUMAN; LIMBIC SYSTEM; MALE; MENTAL DISEASE; MORTALITY; NIGRONEOSTRIATAL SYSTEM; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SCORING SYSTEM; SENILITY; SLEEP WAKING CYCLE; SOMNOLENCE; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 40349100691     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2007.00206.x     Document Type: Article

References (21)

1. Rosen J, Bohon S, Gershon S. Antipsychotics in elderly. Acta Psychiatr Scand 1990; 358: 170-175.
2. Boettger S, Breutbart W. Atypical antipsychotics in the management of delirium: A review of the empirical literature. Palliat Support Care 2005; 3: 227-237.
3. Sipahimalani A, Sime RM, Masand PS. Treatment of delirium with risperidone. Int J Geriatr Psychopharmacol 1997; 1: 24-26.
4. Horikawa N, Yamazaki T, Miyamoto K et al. Treatment for delirium with risperidone: Results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 2003; 25: 289-292.
5. Parellada E, Baeza I, de Pablo J et al. Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004; 65: 348-353.
6. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999; 156: 1-20.
7. Jacobi J, Fraser GL, Coursin DB. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adults. Crit Care Med 2002; 30: 119-141.
8. Cruzan S. FDA Issues Public Health Advisory for Antipsychotic Drugs Used for Treatment of Behavioral Disorders in Elderly Patients. Available online at http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01350.html [accessed 10 June 2006].
9. Wang PS, Schneeweiss S, Avorn J et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335-2341.
10. Ryan CJ. Optimizing management of delirium: Placebo controlled trials of pharmacological treatments are needed. BMJ 2001; 322: 144-149.
11. Kato T, Hirose A, Ohno Y et al. Binding profile of SM-9018, a novel antipsychotic candidate. Jpn J Pharmacol 1990; 54: 478-481.
12. de Paulis T. Perospirone. Curr Opin Invest Drugs 2002; 3: 121-129.
13. Hirose A, Kato T, Ohono Y et al. Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions. Jpn J Pharmacol 1990; 53: 321-329.
14. Yasui-Furukori N, Furukori H, Nakagami T et al. Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response. Ther Drug Monit 2004; 26: 361-365.
15. Sato S, Mizukami K, Moro K et al. Efficacy of perospirone in the management of aggressive behavior associated with dementia. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 679-683.
16. Ito Y. Clinical effects of perospirone on delirium with senile dementia at nursing home care. Jpn J Clin Psychopharmacol 2004; 7: 981-990.
17. Komori K, Komori M, Maekawa K, Kanemoto K. A prospective, open-label, flexible-dose study of perospirone in the treatment of delirium. Jpn J Clin Psychopharmacol 2004; 8: 1449-1454.
18. Trzepacz PT, Baker RW, Greenhouse J. A symptom ratining scale for delirium. Psychiatry Res 1988; 23: 89-97.
19. Trzepacz PT. The Delirium Rating Scale. Its use in consultation-liaison research. Psychosomatics 1999; 40: 193-204.
20. World Health Organization. International Classification of Diseases and Related Health Problems, 10th revision. Geneva: World Health Organization, 1992.
21. 2 and serotonin 2A receptors by novel antipsychotic drug, SM-9018 and its metabolite, in rat brain. J Neural Transm 1998; 105: 181-191.